Embleema

Summary

This business operates a comprehensive data and bioinformatics platform that enhances precision medicine by integrating molecular, clinical, and real-world data. It offers an end-to-end solution for personalized medicine, facilitating participant recruitment, data collection, and regulatory submissions. The platform utilizes blockchain technology to ensure participant consent and provides a secure environment for data sharing. It aims to accelerate regulatory approvals and improve patient involvement in clinical studies.